Blog

Rutgers University has pioneered a decentralized approach to clinical trials that is allowing researchers to achieve better scientific outcomes as they accelerate the pace of finding cures, recruit lower-income and underrepresented populations that were previously unable to engage in clinical trials, and broaden the geographic coverage of studies. “This approach that speeds the process of […]

A growing number of drugs are being approved on the basis of indirect (surrogate) measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better. In a recent issue of The BMJ, experts argue that surrogate endpoints provide no guarantee of clinical benefit and should […]

Australian researchers have been awarded nearly $2.2 million by the U.S. National Cancer Institute (NCI) to test new treatment drugs for children with cancer over the next five years, so the most promising of these can be fast-tracked into clinical trials. The Leukemia Biology Group at Children’s Cancer Institute is the only non-U.S.-based research team […]

Are you a manager of a remote clinical trial workforce? Are you concerned about burning its members out under current conditions? According to a new study led by the Tufts Center for the Study of Drug Development (CSDD), you probably should be. The new study found more than half (55%) of members of clinical research […]

TransCelerate BioPharma Inc. has announced that it has commenced development on a reference implementation of a study definitions repository. The study definitions repository is a novel central component aimed at facilitating the exchange of structured study definitions across clinical systems using technical and data standards. TransCelerate is leading the effort to design, build, and […]